The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility and efficacy of oral 5-FU in combination with pembrolizumab and cisplatin as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma: A prospective observational study.
 
Jason Hsieh
No Relationships to Disclose
 
Pei-Hung Chang
No Relationships to Disclose
 
Meng-Che Hsieh
No Relationships to Disclose
 
Jia-Hong Chen
No Relationships to Disclose
 
Ming-Yu Lien
No Relationships to Disclose
 
Ching-Liang Ho
No Relationships to Disclose
 
Hung-Ming Wang
No Relationships to Disclose
 
Kun-Yun Yeh
No Relationships to Disclose
 
Ching-Yun Hsieh
No Relationships to Disclose